首页 > 最新文献

Journal of Medical Imaging and Radiation Oncology最新文献

英文 中文
Breast Microcalcification in Women Under 40 Years of Age 40岁以下女性乳房微钙化。
IF 1.4 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-11 DOI: 10.1111/1754-9485.70042
Alan J. Porter, Elizabeth B. Evans

Introduction

This study examines the results of vacuum-assisted biopsy (VAB) for suspicious microcalcification as the only significant mammographic finding, with particular reference to women under age 40 years.

Methods

The study cohort comprised symptomatic or asymptomatic women who had full-field digital mammography at the Wesley Breast Clinic over a 9-year period (2013– 2021). Suspicious microcalcification was subjected to vacuum-assisted biopsy (VAB). The histological results were classified as: (a) invasive cancer, (b) ductal carcinoma-in situ (DCIS), (c) atypia, (d) papillary lesions or (e) benign tissue.

Results

Of the 139,911 women examined by mammography, 5967 were under 40 and had mammography because of symptoms or significant risk factors for breast cancer. Overall, 1748 (1.2% of mammograms) revealed a suspicious cluster of microcalcification as the only abnormality. 68 of these were in women under 40 (1.1% of mammograms in these women). A positive result for malignancy, (DCIS or invasive cancer) was obtained in 20.8% of VABs overall, including 16.1% of women under 40 (2 invasive, 9 DCIS). Women under 50 had about half the risk of a malignant result on VAB compared with women aged 50 and over. B3 lesions (of uncertain malignant potential) were uncommon in women under 40.

Conclusions

The small number of women under 40 who had suspicious microcalcification requiring VAB, and of cancers thus found, suggests that, unless significant risk factors are present, it is difficult to justify mammography in women prior to age 35 with the sole aim of detecting microcalcification which could be, for example, DCIS.

简介:本研究检查了可疑微钙化的真空辅助活检(VAB)结果,作为唯一重要的乳房x线摄影发现,特别涉及40岁以下的女性。方法:研究队列包括有症状或无症状的妇女,她们在Wesley乳腺诊所接受了9年(2013- 2021)的全场数字乳房x光检查。可疑的微钙化进行了真空辅助活检(VAB)。组织学结果分为:(a)浸润性癌,(b)导管原位癌(DCIS), (c)异型性癌,(d)乳头状病变或(e)良性组织。结果:在139,911名接受乳房x光检查的女性中,有5967名年龄在40岁以下,由于乳腺癌的症状或重大危险因素而接受乳房x光检查。总的来说,1748例(1.2%)的乳房x光片显示可疑的微钙化簇是唯一的异常。其中68例是40岁以下的女性(占这些女性乳房x光检查的1.1%)。恶性肿瘤(DCIS或浸润性癌)的阳性结果在20.8%的vab中获得,其中包括16.1%的40岁以下女性(2例浸润性,9例DCIS)。与50岁及以上的女性相比,50岁以下的女性患VAB恶性结果的风险约为一半。B3型病变(不确定恶性潜能)在40岁以下女性中少见。结论:少数40岁以下的女性有可疑的微钙化,需要进行VAB检查,并因此发现癌症,这表明,除非存在显著的危险因素,否则很难证明35岁之前的女性进行乳房x光检查的唯一目的是检测微钙化,例如DCIS。
{"title":"Breast Microcalcification in Women Under 40 Years of Age","authors":"Alan J. Porter,&nbsp;Elizabeth B. Evans","doi":"10.1111/1754-9485.70042","DOIUrl":"10.1111/1754-9485.70042","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>This study examines the results of vacuum-assisted biopsy (VAB) for suspicious microcalcification as the only significant mammographic finding, with particular reference to women under age 40 years.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The study cohort comprised symptomatic or asymptomatic women who had full-field digital mammography at the Wesley Breast Clinic over a 9-year period (2013– 2021). Suspicious microcalcification was subjected to vacuum-assisted biopsy (VAB). The histological results were classified as: (a) invasive cancer, (b) ductal carcinoma-in situ (DCIS), (c) atypia, (d) papillary lesions or (e) benign tissue.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of the 139,911 women examined by mammography, 5967 were under 40 and had mammography because of symptoms or significant risk factors for breast cancer. Overall, 1748 (1.2% of mammograms) revealed a suspicious cluster of microcalcification as the only abnormality. 68 of these were in women under 40 (1.1% of mammograms in these women). A positive result for malignancy, (DCIS or invasive cancer) was obtained in 20.8% of VABs overall, including 16.1% of women under 40 (2 invasive, 9 DCIS). Women under 50 had about half the risk of a malignant result on VAB compared with women aged 50 and over. B3 lesions (of uncertain malignant potential) were uncommon in women under 40.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The small number of women under 40 who had suspicious microcalcification requiring VAB, and of cancers thus found, suggests that, unless significant risk factors are present, it is difficult to justify mammography in women prior to age 35 with the sole aim of detecting microcalcification which could be, for example, DCIS.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"70 1","pages":"17-21"},"PeriodicalIF":1.4,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145489076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Do Medical Oncologists Expect From PET/CT Reports 肿瘤学家对PET/CT报告的期望是什么?
IF 1.4 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-07 DOI: 10.1111/1754-9485.70043
Sepinoud Firouzmand, Paul Vasey, Louise McEwan, James Walters, Nigel Sommerfeld, David Wong
{"title":"What Do Medical Oncologists Expect From PET/CT Reports","authors":"Sepinoud Firouzmand,&nbsp;Paul Vasey,&nbsp;Louise McEwan,&nbsp;James Walters,&nbsp;Nigel Sommerfeld,&nbsp;David Wong","doi":"10.1111/1754-9485.70043","DOIUrl":"10.1111/1754-9485.70043","url":null,"abstract":"","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"70 1","pages":"88-89"},"PeriodicalIF":1.4,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145458953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of Quantitative Parameters From Triple-Phase Contrast Enhanced Dual-Energy CT for Predicting Immunohistochemical Biomarkers in Invasive Breast Cancer 三期增强双能CT定量参数预测浸润性乳腺癌免疫组织化学生物标志物的应用
IF 1.4 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-04 DOI: 10.1111/1754-9485.70039
Mingwang Chen, Minfeng Liu, Yuting Wu, Mingjue Jian, Li Ding, Xiaomei Li, Yikai Xu, Chantao Huang, Chenggong Yan

Purpose

To investigate the value of quantitative parameters derived from triple-phase dual-energy CT (DECT) for the discrimination of immunohistochemical biomarkers in invasive breast cancer.

Material and Methods

From March 2022 to May 2023, 41 participants with breast cancer who underwent contrast enhanced (arterial, venous, and equilibrium phase) chest DECT were enrolled in this prospective study. DECT quantitative parameters were measured and compared with the immunohistochemical biomarkers [oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2)] status. Receiver operating characteristic curve analysis was used to determine the diagnostic performance of parameters.

Results

Arterial enhancement fraction (AEF) was significantly higher in the ER-negative group than in the ER-positive group (p = 0.030) with an AUC of 0.786. AEF was identified as an independent predictor for distinguishing PR-negative from PR-positive tumours (AUC = 0.857; OR = 1/e10.515, 95% CI: 0.000–0.205, p = 0.021). Enhancement ratio between venous phase and equilibrium phase (ERVE) was significantly higher in the HER2-positive group in contrast to the HER2-negative group (p = 0.037) with an AUC of 0.781.

Conclusions

Triple-phase DECT-derived parameter AEF was identified as a useful negativity predictor for ER and PR levels, while ERVE was demonstrated as a positivity predictor of HER2 status in invasive breast cancer.

目的:探讨三期双能CT (DECT)定量参数对浸润性乳腺癌免疫组织化学标志物鉴别的价值。材料和方法:从2022年3月到2023年5月,41名接受对比增强(动脉、静脉和平衡期)胸部DECT的乳腺癌患者被纳入这项前瞻性研究。测定DECT定量参数,并与免疫组织化学生物标志物[雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2 (HER2)]状态进行比较。采用受试者工作特征曲线分析确定各参数的诊断性能。结果:er阴性组动脉增强分数(AEF)显著高于er阳性组(p = 0.030), AUC为0.786。AEF被确定为区分pr阴性和pr阳性肿瘤的独立预测因子(AUC = 0.857; OR = 1/e10.515, 95% CI: 0.000-0.205, p = 0.021)。her2阳性组静脉相与平衡相的增强比(ERVE)显著高于her2阴性组(p = 0.037), AUC为0.781。结论:三相dect衍生参数AEF被确定为ER和PR水平的有用阴性预测因子,而ERVE被证明是浸润性乳腺癌中HER2状态的阳性预测因子。
{"title":"Utility of Quantitative Parameters From Triple-Phase Contrast Enhanced Dual-Energy CT for Predicting Immunohistochemical Biomarkers in Invasive Breast Cancer","authors":"Mingwang Chen,&nbsp;Minfeng Liu,&nbsp;Yuting Wu,&nbsp;Mingjue Jian,&nbsp;Li Ding,&nbsp;Xiaomei Li,&nbsp;Yikai Xu,&nbsp;Chantao Huang,&nbsp;Chenggong Yan","doi":"10.1111/1754-9485.70039","DOIUrl":"10.1111/1754-9485.70039","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>To investigate the value of quantitative parameters derived from triple-phase dual-energy CT (DECT) for the discrimination of immunohistochemical biomarkers in invasive breast cancer.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Material and Methods</h3>\u0000 \u0000 <p>From March 2022 to May 2023, 41 participants with breast cancer who underwent contrast enhanced (arterial, venous, and equilibrium phase) chest DECT were enrolled in this prospective study. DECT quantitative parameters were measured and compared with the immunohistochemical biomarkers [oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2)] status. Receiver operating characteristic curve analysis was used to determine the diagnostic performance of parameters.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Arterial enhancement fraction (AEF) was significantly higher in the ER-negative group than in the ER-positive group (<i>p</i> = 0.030) with an AUC of 0.786. AEF was identified as an independent predictor for distinguishing PR-negative from PR-positive tumours (AUC = 0.857; OR = 1/e<sup>10.515</sup>, 95% CI: 0.000–0.205, <i>p</i> = 0.021). Enhancement ratio between venous phase and equilibrium phase (ERVE) was significantly higher in the HER2-positive group in contrast to the HER2-negative group (<i>p</i> = 0.037) with an AUC of 0.781.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Triple-phase DECT-derived parameter AEF was identified as a useful negativity predictor for ER and PR levels, while ERVE was demonstrated as a positivity predictor of HER2 status in invasive breast cancer.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"70 1","pages":"7-16"},"PeriodicalIF":1.4,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145438176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Analysis of Infection Rates Between Supra-Ampullary and Trans-Ampullary Biliary Stent Placements in Biliary Sepsis 胆道败血症中壶腹上胆道支架与经壶腹胆道支架感染率的比较分析。
IF 1.4 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-04 DOI: 10.1111/1754-9485.70040
Arkan Youssef, Ahmed Siddiqui, John Vrazas

Introduction

Biliary stent placement is a critical palliative treatment for obstructive jaundice due to malignancies. The site, either supra-ampullary (above the ampulla of Vater) or trans-ampullary (below the ampulla of Vater), may influence complication rates which significantly impact patient outcomes. This study evaluates the infection and obstruction rates associated with these two distinct stent placement strategies.

Methods

Data from 66 patients who underwent biliary stent placements between 2017 and 2022 at our institution were analysed. Patients were categorised into two groups based on stent placement: supra-ampullary (12 patients) and trans-ampullary (54 patients). We assessed the incidence of infection within 30 and 90 days post-procedure and in these patients evidence of radiological stent obstruction.

Results

In the supra-ampullary group, infection rates were 41.67% within 30 days and 58.33% within 90 days post-procedure. The trans-ampullary group exhibited infection rates of 12.96% within 30 days and 20.37% within 90 days. Higher infection rates were observed in the supra-ampullary group at 30 days, and this difference was statistically significant (p = 0.020). The difference in infection rates at 90 days was also statistically significant (p = 0.008). In cases of infection where stent patency was investigated, radiologically confirmed stent obstructions (either stenosis or occlusion) within 90 days were not statistically significant (p = 0.296).

Conclusion

Supra-ampullary stent placements are associated with higher rates of post-procedural infections compared to trans-ampullary placements at both timepoints, highlighting the importance of selecting optimal stent placement strategies to reduce infection rates and improve patient outcomes.

导言:胆道支架置入术是恶性肿瘤梗阻性黄疸的关键姑息性治疗。无论是壶腹上(壶腹以上)还是壶腹下(壶腹以下),都可能影响并发症发生率,从而显著影响患者的预后。本研究评估了与这两种不同的支架置入策略相关的感染和阻塞率。方法:分析我院2017年至2022年间接受胆道支架置入的66例患者的数据。患者根据支架放置分为两组:壶腹上支架(12例)和经壶腹支架(54例)。我们评估了术后30天和90天内感染的发生率,以及这些患者放射学支架阻塞的证据。结果:壶腹上组术后30 d内感染率为41.67%,90 d内感染率为58.33%。经壶腹组30天感染率为12.96%,90天感染率为20.37%。30 d时壶腹上组感染率较高,差异有统计学意义(p = 0.020)。90 d感染率差异也有统计学意义(p = 0.008)。在调查支架通畅的感染病例中,90天内影像学证实的支架阻塞(狭窄或闭塞)无统计学意义(p = 0.296)。结论:在这两个时间点,与经壶腹支架置入相比,壶腹上支架置入的术后感染率更高,这突出了选择最佳支架置入策略以降低感染率和改善患者预后的重要性。
{"title":"Comparative Analysis of Infection Rates Between Supra-Ampullary and Trans-Ampullary Biliary Stent Placements in Biliary Sepsis","authors":"Arkan Youssef,&nbsp;Ahmed Siddiqui,&nbsp;John Vrazas","doi":"10.1111/1754-9485.70040","DOIUrl":"10.1111/1754-9485.70040","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Biliary stent placement is a critical palliative treatment for obstructive jaundice due to malignancies. The site, either supra-ampullary (above the ampulla of Vater) or trans-ampullary (below the ampulla of Vater), may influence complication rates which significantly impact patient outcomes. This study evaluates the infection and obstruction rates associated with these two distinct stent placement strategies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data from 66 patients who underwent biliary stent placements between 2017 and 2022 at our institution were analysed. Patients were categorised into two groups based on stent placement: supra-ampullary (12 patients) and trans-ampullary (54 patients). We assessed the incidence of infection within 30 and 90 days post-procedure and in these patients evidence of radiological stent obstruction.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In the supra-ampullary group, infection rates were 41.67% within 30 days and 58.33% within 90 days post-procedure. The trans-ampullary group exhibited infection rates of 12.96% within 30 days and 20.37% within 90 days. Higher infection rates were observed in the supra-ampullary group at 30 days, and this difference was statistically significant (<i>p</i> = 0.020). The difference in infection rates at 90 days was also statistically significant (<i>p</i> = 0.008). In cases of infection where stent patency was investigated, radiologically confirmed stent obstructions (either stenosis or occlusion) within 90 days were not statistically significant (<i>p</i> = 0.296).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Supra-ampullary stent placements are associated with higher rates of post-procedural infections compared to trans-ampullary placements at both timepoints, highlighting the importance of selecting optimal stent placement strategies to reduce infection rates and improve patient outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"69 8","pages":"829-835"},"PeriodicalIF":1.4,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145438181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive Value of Magnetic Resonance Imaging of the Knee in the Evaluation/Quantification of Osteoporosis: A Comparative Analysis With Dual-Energy X-Ray Absorptiometry 膝关节磁共振成像在骨质疏松症评估/量化中的预测价值:与双能x线吸收仪的比较分析。
IF 1.4 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-31 DOI: 10.1111/1754-9485.70038
Elias Petrou, Nathan Jenko, Hasaam Uldin, Kapil Shirodkar, Karthikeyan P. Iyengar, Madava G. Djearaman, Rajesh Botchu

Background

Dual-energy X-ray absorptiometry (DEXA) remains the gold standard test for the assessment of bone density. In a previous Magnetic Resonance Imaging (MRI) study of the lumbar spine it has been noted that when the T1 vertebral body/CSF (cerebrospinal fluid) ratio is high it is suggestive of osteoporosis.

Purpose

The aim of this study is to investigate whether the relative signal intensity of the imaged bone marrow in the knee compared to the other structures can also be used to detect osteoporosis.

Patients and Methods

A total of 103 patients who had undergone both a knee MRI and a DEXA scan within the same 12-month period were identified. The T1/PD (Proton Density) and FS (Fat Suppression) signal intensity of marrow (of the femur, tibia and patella), vastus medialis muscle, joint fluid and subcutaneous fat were measured within a region of interest, and the signal intensity ratios were calculated. The ratios were stratified as normal, osteopenic, or osteoporotic based on DEXA T-scores. The correlation between the signal intensity ratios and the DEXA T-score was evaluated using Pearson's linear coefficient and ROC analysis. Intraclass correlation coefficients (ICC) were also calculated.

Results

The bone marrow (FS)/joint fluid (FS) ratio was significantly higher in the osteoporotic group than in the normal and osteopenic groups (femoral p = 0.0018, patellar bone marrow (tibia) p = 0.0003 and pooled p = 0.0022). The intraobserver (ICC = 0.923–0.974) and interobserver reliability (ICC = 0.803–0.945) were excellent.

Conclusion

The bone marrow/joint fluid (FS) ratios of the knee MRI have some predictive value for the presence of osteoporosis.

背景:双能x线吸收仪(DEXA)仍然是评估骨密度的金标准测试。在之前的腰椎磁共振成像(MRI)研究中已经注意到,当T1椎体/脑脊液(脑脊液)比例高时,提示骨质疏松症。目的:本研究的目的是探讨膝关节骨髓成像相对于其他结构的相对信号强度是否也可用于骨质疏松症的检测。患者和方法:共有103例患者在相同的12个月内接受了膝关节MRI和DEXA扫描。测量感兴趣区域内骨髓(股骨、胫骨和髌骨)、股内侧肌、关节液和皮下脂肪的T1/PD(质子密度)和FS(脂肪抑制)信号强度,并计算信号强度比。根据DEXA t评分将比率分为正常、骨质减少或骨质疏松。采用Pearson线性系数和ROC分析评价信号强度比与DEXA t评分之间的相关性。并计算了类内相关系数(ICC)。结果:骨质疏松组骨髓(FS)/关节液(FS)比值明显高于正常组和骨质减少组(股骨p = 0.0018,髌骨骨髓(胫骨)p = 0.0003,合并p = 0.0022)。观察者内信度(ICC = 0.923-0.974)和观察者间信度(ICC = 0.803-0.945)均极好。结论:膝关节MRI骨髓/关节液(FS)比值对骨质疏松的存在有一定的预测价值。
{"title":"Predictive Value of Magnetic Resonance Imaging of the Knee in the Evaluation/Quantification of Osteoporosis: A Comparative Analysis With Dual-Energy X-Ray Absorptiometry","authors":"Elias Petrou,&nbsp;Nathan Jenko,&nbsp;Hasaam Uldin,&nbsp;Kapil Shirodkar,&nbsp;Karthikeyan P. Iyengar,&nbsp;Madava G. Djearaman,&nbsp;Rajesh Botchu","doi":"10.1111/1754-9485.70038","DOIUrl":"10.1111/1754-9485.70038","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Dual-energy X-ray absorptiometry (DEXA) remains the gold standard test for the assessment of bone density. In a previous Magnetic Resonance Imaging (MRI) study of the lumbar spine it has been noted that when the T1 vertebral body/CSF (cerebrospinal fluid) ratio is high it is suggestive of osteoporosis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>The aim of this study is to investigate whether the relative signal intensity of the imaged bone marrow in the knee compared to the other structures can also be used to detect osteoporosis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patients and Methods</h3>\u0000 \u0000 <p>A total of 103 patients who had undergone both a knee MRI and a DEXA scan within the same 12-month period were identified. The T1/PD (Proton Density) and FS (Fat Suppression) signal intensity of marrow (of the femur, tibia and patella), vastus medialis muscle, joint fluid and subcutaneous fat were measured within a region of interest, and the signal intensity ratios were calculated. The ratios were stratified as normal, osteopenic, or osteoporotic based on DEXA T-scores. The correlation between the signal intensity ratios and the DEXA T-score was evaluated using Pearson's linear coefficient and ROC analysis. Intraclass correlation coefficients (ICC) were also calculated.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The bone marrow (FS)/joint fluid (FS) ratio was significantly higher in the osteoporotic group than in the normal and osteopenic groups (femoral <i>p</i> = 0.0018, patellar bone marrow (tibia) <i>p</i> = 0.0003 and pooled <i>p</i> = 0.0022). The intraobserver (ICC = 0.923–0.974) and interobserver reliability (ICC = 0.803–0.945) were excellent.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The bone marrow/joint fluid (FS) ratios of the knee MRI have some predictive value for the presence of osteoporosis.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"69 8","pages":"815-820"},"PeriodicalIF":1.4,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145421889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RO Oral Abstracts RO口头摘要
IF 1.4 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-29 DOI: 10.1111/1754-9485.70035
{"title":"RO Oral Abstracts","authors":"","doi":"10.1111/1754-9485.70035","DOIUrl":"https://doi.org/10.1111/1754-9485.70035","url":null,"abstract":"","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"69 S2","pages":"S177-S216"},"PeriodicalIF":1.4,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145384955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acknowledgement 确认
IF 1.4 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-29 DOI: 10.1111/1754-9485.70037
{"title":"Acknowledgement","authors":"","doi":"10.1111/1754-9485.70037","DOIUrl":"https://doi.org/10.1111/1754-9485.70037","url":null,"abstract":"","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"69 S2","pages":"S4-S5"},"PeriodicalIF":1.4,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145384957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interventional Radiology and Interventional Neuroradiology Oral Abstracts 介入放射学与介入神经放射学口头文摘
IF 1.4 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-29 DOI: 10.1111/1754-9485.70036
{"title":"Interventional Radiology and Interventional Neuroradiology Oral Abstracts","authors":"","doi":"10.1111/1754-9485.70036","DOIUrl":"https://doi.org/10.1111/1754-9485.70036","url":null,"abstract":"","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"69 S2","pages":"S275-S284"},"PeriodicalIF":1.4,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145384968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiology Posters 2025 Abstract 放射学海报2025摘要
IF 1.4 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-29 DOI: 10.1111/1754-9485.70031
{"title":"Radiology Posters 2025 Abstract","authors":"","doi":"10.1111/1754-9485.70031","DOIUrl":"https://doi.org/10.1111/1754-9485.70031","url":null,"abstract":"","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"69 S2","pages":"S31-S145"},"PeriodicalIF":1.4,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145384970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiology Orals 2025 Abstracts 放射学口腔2025摘要
IF 1.4 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-29 DOI: 10.1111/1754-9485.70034
{"title":"Radiology Orals 2025 Abstracts","authors":"","doi":"10.1111/1754-9485.70034","DOIUrl":"https://doi.org/10.1111/1754-9485.70034","url":null,"abstract":"","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"69 S2","pages":"S217-S274"},"PeriodicalIF":1.4,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145384956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Medical Imaging and Radiation Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1